CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

Ítems similars

• CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers
  per: Pelekanou, Vasiliki, et al.
  Publicat: (2018)
• Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
  per: Talvensaari-Mattila, A, et al.
  Publicat: (2003)
• Matrix metalloproteinase (MMP)-2 and MMP-9 in seminal plasma
  per: Tentes, Ioannis, et al.
  Publicat: (2007)
• Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
  per: Kim, T. S., et al.
  Publicat: (1999)
• Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth
  per: Orozco-Páez, Jennifer, et al.
  Publicat: (2021)